These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17064072)

  • 1. A novel class of carbonic anhydrase inhibitors: glycoconjugate benzene sulfonamides prepared by "click-tailing".
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Supuran CT; Poulsen SA
    J Med Chem; 2006 Nov; 49(22):6539-48. PubMed ID: 17064072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    Bioorg Med Chem Lett; 2007 Feb; 17(4):987-92. PubMed ID: 17157501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
    Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
    Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides.
    Wilkinson BL; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2008 Mar; 51(6):1945-53. PubMed ID: 18307288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
    Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety.
    Salmon AJ; Williams ML; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5032-5. PubMed ID: 17681760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
    Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties.
    Singer M; Lopez M; Bornaghi LF; Innocenti A; Vullo D; Supuran CT; Poulsen SA
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2273-6. PubMed ID: 19286378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
    Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
    Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX.
    Thiry A; Ledecq M; Cecchi A; Dogné JM; Wouters J; Supuran CT; Masereel B
    J Med Chem; 2006 May; 49(9):2743-9. PubMed ID: 16640335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A; Menabuoni L; Mincione F; Briganti F; Mincione G; Supuran CT
    J Med Chem; 1999 Jul; 42(14):2641-50. PubMed ID: 10411484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails.
    Winum JY; Thiry A; Cheikh KE; Dogné JM; Montero JL; Vullo D; Scozzafava A; Masereel B; Supuran CT
    Bioorg Med Chem Lett; 2007 May; 17(10):2685-91. PubMed ID: 17376683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
    Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing of novel carbonic anhydrase inhibitors and activators.
    Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A
    Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbonic anhydrase inhibitors. Inhibition of the cytosolic human isozymes I and II, and the transmembrane, tumor-associated isozymes IX and XII with substituted aromatic sulfonamides activatable in hypoxic tumors.
    Saczewski F; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4846-51. PubMed ID: 16809036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX.
    Turkmen H; Durgun M; Yilmaztekin S; Emul M; Innocenti A; Vullo D; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jan; 15(2):367-72. PubMed ID: 15603956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.